AION Diagnostics, Inc : modified porous silicon
| Their contrast agent is based on modified porous silicon. The material is known to be visible in ultrasound as well as MRI, CT & optical imaging. |
Company Web Site:modified porous silicon |
| Ultrasound Contrast Agents | |
| Approved | In Development |
| Bracco: SonoVue® | Acusphere, Inc™: magify™ |
| Bristol-Myers Squibb: DEFINITY® | AION Diagnostics, Inc: modified porous silicon |
| GE: OPTISON™ | Targeson, LLC: Targestar™ |
| IMACOR: Imagent | ImaRx Therapeutics, Inc: SonoLysis™ |
| POINT Biomedical: CARDIOsphere™ | |
Please Note:
The trademarks, copyrights, company, product , & organization names shown on this site are provided for reference purposes. Each is owned by the respective companies & organizations. Unless stated otherwise, none are affiliated with EchoChief.com or its publisher, Insonoart, Inc.
The web sites of Insonoart, Inc are not intended to provide medical advice, nor is any information here a substitute for professional healthcare. Consult your doctor or other healthcare provider for information about your diagnosis, treatment or condition.
